Use of multiple, sequential light and laser sources to activate aminolevulinic acid (ALA) in photodynamic therapy (PDT) does not lead to statistically significant improvements in patient outcome for rosacea, according to a study published online July 4 in the Journal of Cosmetic Dermatology.